Source: Covexit


In this video, Dr Peter McCullough, from the Baylor University Medical Center in Texas, explains how important early outpatient treatment is and presents guidelines for such treatment.

He relies on an article on outpatient treatment published by himself and several co-authors, including Yale professor, medical doctor and epidemiologist Harvey Risch.

Dr McCullough collaborated with medical doctors in the US and Italy to come up with practical guidelines for practitioners for the early outpatient treatment of COVID-19.

He explains that patients who present to hospital generally do so after two weeks of illness, and are already severely ill.

They are put into isolation, do receive supportive care, and there has been some advancement with therapies. Hopefully they will survive, he says, adding, that sadly, many won’t.

“Outpatient treatment is the only hope for reducing the risk of hospitalization and death” affirms Dr McCullough

Dr McCullough and his collaborators developed an emergency program for the outpatient treatment of COVID-19. 

The findings were published in the American Journal of Medicine on August 6. 

Dr McCullough present them as the first published peer reviewed treatment guidelines for practitioners who are caring for ambulatory COVID-19 patients.


Belgium Study: Low-dose Hydroxychloroquine Therapy and Mortality (Lowered) in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants update: Now 88 international studies (51 peer reviewed) show positive hydroxychloroquine treatment outcomes

Italy Study 3,451 patients: Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

China Study of 2882 patients: Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories